发明名称 |
Systems for Sustained Intraocular Delivery of Low Solubility Compounds from a Port Delivery System Implant |
摘要 |
Therapeutic agent delivery formulations for the sustained release of therapeutic agents from a Port Delivery System (PDS) implant is described in this application. |
申请公布号 |
US2014276482(A1) |
申请公布日期 |
2014.09.18 |
申请号 |
US201414212817 |
申请日期 |
2014.03.14 |
申请人 |
ForSight Vision4, Inc. |
发明人 |
Astafieva Irina;Horvath Judit;Farinas Kathleen Cogan;Bueche Blaine;Erickson Signe |
分类号 |
A61K31/506;A61K31/444;A61K31/416;A61K31/404;A61K31/4439 |
主分类号 |
A61K31/506 |
代理机构 |
|
代理人 |
|
主权项 |
1. A therapeutic agent delivery system comprising a therapeutic device having a reservoir chamber coupled to a porous structure for controlled release of a therapeutic agent in the vitreous of the eye and a formulation comprising a therapeutic agent and one or more formulation agents, wherein the formulation is contained in the reservoir of the therapeutic device; and the controlled release of the therapeutic agent and formulation agents from the reservoir through the porous structure increases the half-life of the therapeutic agent in the vitreous. |
地址 |
Menlo Park CA US |